Clinical Trial Update: Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures [NA]

View source ↗

Summary

A completed pediatric trial evaluating THRIVE use during procedures; results posted in 2020 without further regulatory actions described.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia-associated Adverse Effects
• Desaturation of Blood
• Hypoventilation
• Oxygen Deficiency

Snippet

Sponsor: Stanford University | Conditions: Oxygen Deficiency, Desaturation of Blood | NA | Status: COMPLETED | Results posted: 2020-08-06